Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

By  

Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. : 131-138

Bentham Science Publishers

Access to resources Recommend Favorite

3-Phenyl-1H-Indole-5-Sulfonamides: Structure-Based Drug Design of a Promising Class of Carbonic Anhydrase Inhibitors

By  

Current Pharmaceutical Design, Vol. 16, Iss. 29, 2010-10 ,pp. : 3317-3326

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based Design of Mimetics for Granulocyte-macrophage Colony Stimulating Factor (GM-CSF)

By  

Current Pharmaceutical Design, Vol. 8, Iss. 24, 2002-11 ,pp. : 2185-2199

Bentham Science Publishers

Access to resources Recommend Favorite

Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-05 ,pp. : 655-676

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based design in drug discovery - the application of a peptoid drug design strategy for the development of non-peptide neuropeptide receptor ligands

By Pritchard M.C.   Raphy J.   Singh L.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 349-365

Informa Healthcare

Access to resources Recommend Favorite